Humanetics extends long COVID drug trial to more sites
Humanetics has expanded clinical trial of a new oral drug, BIO 300, for long-haul Covid-19 (long COVID) to include two more US study sites.
Source: clinicaltrialsarena.com
Stay updated with breaking news from Humanetics Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Humanetics has expanded clinical trial of a new oral drug, BIO 300, for long-haul Covid-19 (long COVID) to include two more US study sites.